Provider of private cervical screening services to use LBC screening technology from cancer and pathology services group
Medical Solutions, a cancer and pathology services group, reports that Doctors Laboratory, a provider of private cervical screening in the UK, is adopting Medical Solutions's SurePath for their LBC screening.
SurePath system will be supplied by Medical Solutions in the UK under licence from TriPath Imaging.
SurePath has recently demonstrated to the Food and Drug Administration a 64.4% improvement in detection of high-grade lesions compared to conventional smear screening.
The SurePath screening process uses a high throughput PrepStain robot to produce slides, which are highly consistent and very clear to read so there is never any need to reprocess specimens to remove excess red cells.
SurePath also provides a unique collection system whereby the brush head is transferred to the collection vial, thus ensuring 100% of the sample cells from the cervix are retained and are sent to the laboratory for examination and so eliminating the need for another smear sample to be taken.
Charles Green, chief executive of Medical Solutions, said: "This decision by Doctors Laboratory, which is, by far, the largest provider of private cervical screening in the UK, is a great endorsement for the SurePath system.
"We now eagerly await the Nice (the National Institute of Clinical Excellence) report issuing its final guidance to the NHS, after its preliminary report recommended the use of liquid based cytology within the NHS. "This report is expected in September".
